- Article
225Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins
- Tania Hernández-Jiménez,
- Guillermina Ferro-Flores,
- Enrique Morales-Ávila,
- Keila Isaac-Olivé,
- Blanca Ocampo-García,
- Liliana Aranda-Lara,
- Clara Santos-Cuevas,
- Myrna Luna-Gutiérrez,
- Laura De Nardo and
- Laura Meléndez-Alafort
- + 1 author
Actinium-225 and other alpha-particle-emitting radionuclides have shown high potential for cancer treatment. Reconstituted high-density lipoproteins (rHDL) specifically recognize the scavenger receptor B type I (SR-BI) overexpressed in several types...